Prolonged survival in metastatic colorectal cancer following chemotherapy
作者： Doru Paul , Menachem Gold , Nouraddin Nouraddin
DOI: 10.1002/CCR3.109
关键词:
摘要: Key Clinical Message The cost of treating metastatic colorectal cancer has increased significantly after the introduction targeted antivascular therapies. We report unusual case a patient with several large liver metastases at diagnosis, who was cured removal primary tumor and treatment 5-FU/LV only.
researchgate.net 
sci-hub.se 参考文章(19)
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. Journal of Clinical Oncology. ,vol. 22, pp. 3766- 3775 ,(2004) , 10.1200/JCO.2004.03.104
Barbara Anne Jennings, Chun Shing Kwok, Gavin Willis, Victoria Matthews, Pawel Wawruch, Yoon Kong Loke, Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysis. Pharmacogenetics and Genomics. ,vol. 22, pp. 290- 304 ,(2012) , 10.1097/FPC.0B013E328351875D
Daniel B. Longley, D. Paul Harkin, Patrick G. Johnston, 5-Fluorouracil: mechanisms of action and clinical strategies Nature Reviews Cancer. ,vol. 3, pp. 330- 338 ,(2003) , 10.1038/NRC1074
K Bracht, A M Nicholls, Y Liu, W F Bodmer, 5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency British Journal of Cancer. ,vol. 103, pp. 340- 346 ,(2010) , 10.1038/SJ.BJC.6605780
Grace K. Dy, Timothy J. Hobday, Garth Nelson, Harold E. Windschitl, Michael J. O'Connell, Steven R. Alberts, Richard M. Goldberg, Daniel A. Nikcevich, Daniel J. Sargent, Long-Term Survivors of Metastatic Colorectal Cancer Treated with Systemic Chemotherapy Alone: A North Central Cancer Treatment Group Review of 3811 Patients, N0144 Clinical Colorectal Cancer. ,vol. 8, pp. 88- 93 ,(2009) , 10.3816/CCC.2009.N.014
N Perez, C Tournigand, M Mabro, J.-L Molitor, P Artru, E Carola, T André, C Louvet, M Krulik, A de Gramont, Survie à long terme des cancers colorectaux métastatiques sous chimiothérapie par 5-fluoro-uracile Revue de Médecine Interne. ,vol. 25, pp. 124- 128 ,(2004) , 10.1016/S0248-8663(03)00214-5
Renata Ferrarotto, Priyanka Pathak, Dipen Maru, Atin Agarwal, Michael Overman, Paulo M. Hoff, Scott Kopetz, Durable Complete Responses in Metastatic Colorectal Cancer Treated with Chemotherapy Alone Clinical Colorectal Cancer. ,vol. 10, pp. 178- 182 ,(2011) , 10.1016/J.CLCC.2011.03.023
Arzu Gunes, Ugur Coskun, Cem Boruban, Nazan Gunel, Melih O. Babaoglu, Orhan Sencan, Atila Bozkurt, Anders Rane, Moustapha Hassan, Hakan Zengil, Umit Yasar, Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patients Basic & Clinical Pharmacology & Toxicology. ,vol. 98, pp. 197- 200 ,(2006) , 10.1111/J.1742-7843.2006.PTO_304.X
Scott Kopetz, George J. Chang, Michael J. Overman, Cathy Eng, Daniel J. Sargent, David W. Larson, Axel Grothey, Jean-Nicolas Vauthey, David M. Nagorney, Robert R. McWilliams, Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy Journal of Clinical Oncology. ,vol. 27, pp. 3677- 3683 ,(2009) , 10.1200/JCO.2008.20.5278
Axel Grothey, Mary M. Sugrue, David M. Purdie, Wei Dong, Daniel Sargent, Eric Hedrick, Mark Kozloff, Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE) Journal of Clinical Oncology. ,vol. 26, pp. 5326- 5334 ,(2008) , 10.1200/JCO.2008.16.3212